AzTrials
AzTrials

Rotator Cuff TearsVISUMIRNCT04223440

Ultrasonographic and MRI Explorations of Infraspinatus Muscle in Postero-superior Rotator Cuff Tear

A study testing MRI and ultrasonographic explorations in people with Rotator Cuff Tears, run by University Hospital, Tours at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The project aims to evaluate the contribution of texture analysis on MRI sections, and the technical feasibility, reproducibility, and clinical relevance of quantitative ultrasound and elastography to characterize the composition and volume of infraspinatus muscle in postero-superior rotator cuff tears. Read more about this study

Who is it for?
Ages 35 to 75 years
Conditions the study is for
Rotator Cuff Tears
What is being tested?
MRI and ultrasonographic explorations
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3 participants
Where
1 siteFrance
Study dates
24 Nov 2020to 19 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥ 35 years-old and ≤75 years-old
  • tendonous, transfixing, postero-superior, unilateral and symptomatic rotator cuff lesions
  • controlateral shoulder without symptom, without rotator cuff injuries, without medical ou surgical history
  • written informed consent
  • affiliation to a social security system

Who cannot join

  • pregnant woman
  • patient under legal protection
  • contraindications to MRI
  • traumatic or surgical or medical relevant history on shoulder
  • general or local disease affecting the skeletal striated muscle

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Tours

    Tours, 37044

Other trials in France

About this study

The project aims to evaluate the contribution of texture analysis on MRI sections, and the technical feasibility, reproducibility, and clinical relevance of quantitative ultrasound and elastography to characterize the composition and volume of infraspinatus muscle in postero-superior rotator cuff tears. The perspectives are to optimize the imaging to allow a quantitative, objective and reproducible analysis of the muscle tissue and its characteristics.

Read the detailed description

The rotator cuff of the shoulder consists of 4 tendinomuscular units including the infraspinatus. This complex system fulfils a double role: stabilization/coaptation (raising the arm) and arm mobility (especially external rotation). Rupture of rotator cuff tendons is frequent (> 80% among chronic shoulder pain). They go with a decrease in muscle volume (amyotrophy) and irreversible fat infiltration. The treatment is medical and then surgical (if necessary). The degrees of atrophy and muscle infiltration (especially infraspinatus) are the criteria of choice for surgery. Actually, they are assessed in MRI according to the classification of Fuchs; it is operator dependent, qualitative and poorly reproducible with a strong inter-observer variability. Our team highlighted (2016) the possibility of using texture analysis software to objectively measure the proportion of fatty tissue on MRI sections of the cuff rotator muscles. This work also showed the possibility of using mode B ultrasound for morphological imaging and shear wave elastography to estimate the elasticity of the infraspinatus. The project aims to evaluate the contribution of texture analysis on MRI sections, and the technical feasibility, reproducibility, and clinical relevance of quantitative ultrasound and elastography to characterize the composition and volume of infraspinatus muscle in postero-superior rotator cuff tears. The perspectives are to optimize the imaging to allow a quantitative, objective and reproducible analysis of the muscle tissue and its characteristics.

Being tested
MRI, ultrasonographic explorations
Keywords
Rotator Cuff Tears, MRI, Ultrasonographic explorations
Medical subject headings
Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIOther

    MRI on both shoulder

  • ultrasonographic explorationsOther

    ultrasound and elastography explorations on both shoulder

Study groups in NCT04223440
Study groupRoleWhat they receive
Postero-superior Rotator Cuff TearExperimentalMRI, ultrasonographic explorations
Receives: Other: MRI; Other: ultrasonographic explorations
Healthy Postero-superior Rotator CuffOtherMRI, ultrasonographic explorations
Receives: Other: MRI; Other: ultrasonographic explorations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MRI Texture Index (MTI)

    MRI texture index (MTI) on the healthy side and pathological side

    Measured: up to 2 months

Secondary outcomes (2)
  1. Ultrasound Texture Index (UTI)

    Ultrasound Texture Index (UTI) on the healthy side and pathological side

    Measured: up to 2 months

  2. velocity of shear wave in m.s-1

    shear wave velocity on the healthy side and pathological side

    Measured: up to 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2020
  2. Study start24 Nov 2020
  3. Primary completion19 Mar 2021
  4. Study completion19 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
3 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04223440
Sponsor's protocol ID
DR190044
Acronym
VISUMIR
Status last verified
Feb 2026
First submitted
6 Jan 2020
Last updated
13 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MRI and ultrasonographic explorations in people with Rotator Cuff Tears, run by University Hospital, Tours at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MRI Texture Index (MTI) (time frame: up to 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in